[1]
D. Sutlović, Z. Kljucevic, and S. Kuret, “ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients”, Arh Hig Rada Toksikol, vol. 71, no. 4, Nov. 2020, doi: 10.2478/aiht-2020-71-3378.